Skip to content

SISU - A randomised-controlled trial for the evaluation of SISU, a software agent providing a self-help writing intervention to uplift psychological wellbeing

SISU - A randomised-controlled trial for the evaluation of SISU, a software agent providing a self-help writing intervention to uplift psychological wellbeing - SISU

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016799
Enrollment
120
Registered
2019-04-25
Start date
2019-05-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Having a disorder is no inclusion/exclusion criterium for the study. People, that want to try an innovative technology in the context of a brief psychological intervention to upflift psychological wellbeing with a medium to low psychological wellbeing (WHO-5).

Interventions

Group 1: intervention group: on three consecutive days, participants receive a therapeutic writing intervention consisting of a writing task as well as a mindfulness-based excercise. Group 2: waitlis

Sponsors

Abteilung für Klinische Psychologie und Psychotherapie, Institut für Psychologie und Pädagogik, Universität Ulm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: sufficient knowledge of German language 18 years of age or older informed consent internet-access, E-mail-adresse

Exclusion criteria

Exclusion criteria: psychological wellbeing WHO-5-score > 52

Design outcomes

Primary

MeasureTime frame
psychological wellbeing (WHO-5 at T2)

Secondary

MeasureTime frame
emotional wellbeing (FS-D), psychological flexibility (FAH-II), quality of life (AQoL), satisfaction (ZUF-8), negative effects (INEP), open questions regarding the interaction with SISU personality (BFI-10), expectancy questionnaire (CEQ), emotion regulation (ERQ), alexithymia (TAS-20), technological alliance (TAI-SF) Centrality of event scale (CES) Measurement points of the study: T0: baseline, prior to the first session T1: after the second session T2: after the third session T3: follow-up 4 weeks after randomisation

Countries

Austria, Germany, Switzerland

Contacts

Public ContactEileen Bendig (M.Sc.)

Abteilung für klinische Psychologie und Psychotherapie, Institut für Psychologie und Pädagogik, Universität Ulm

eileen.bendig@uni-ulm.de07315032807

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026